HYPOCHOLESTEROLEMIC EFFECT AND PIGMENTS COMPOSITION OF HERBAL MEDICINE CONTAINING HIGHER AND LOWER PLANTS
Objective: The objective of this research was to investigate the antihypercholesterolemic activity of herbal medicine which consisted of pigment-rich simplicia from higher and lower plants, as well as to determine its pigments composition.
Methods: Sprague-Dawley male rats were randomly divided into five cholesterol-rich diet groups as well as one negative control group with a normal diet, in order to investigate its effect on plasma lipid. The new herbal formulation was administered orally to induced-rats at three dosage levels, whereas simvastatin was used as a comparable generic drug. Pigments composition was determined by means of reversed-phase high-performance liquid chromatography (HPLC) using gradient protocol, monitored with diode array detector at 430 nm.
Results: The administration of herbal medicine was able to significantly reduce total plasma cholesterol and low-density lipoprotein-cholesterol (p<0.05) at a dose of 312.5 mg/kg of body weight/day compared to positive control group, and hence the atherogenic index was also lowered. The chromatographic analysis of pigments determination and quantification are reported correspondingly to support the possible active compounds data of hypocholesterolemic property.
Conclusion: The results obtained in this research work indicated the potency of pigment-rich lower plants to substitute the obtrusive exploration and dominant use of higher plants for treating dyslipidemia.Â
2. Tripathi P, Singh A. Natural resources from plants in the treatment of cancer: an update. Asian J Pharm Clin Res 2017;10:13-22.
3. Ernst E. Prevalence of use of complementary/alternative medicine: a systematic review. Bull World Health Organ 2000;78:258-66.
4. Ernst E, White A. The BBC survey of complementary medicine use in the UK. Complementary Ther Med 2000;8:32-6.
5. Foster DF, Phillips RS, Hamel MB, Eisenberg DM. Alternative medicine use in older Americans. J Am Geriatr Soc 2000;48:1560-5.
6. Oshima E. Medicinal uses of seaweed in traditional chinese medicine. In: Adams JD, Lien EJ. editors. Traditional Chinese medicine: scientific basis for its use. Cambridge: Royal Society of Chemistry; 2013. p. 238-63.
7. Hamza AH, Hegazi MM, Youness ER, Ahmed HH. Brown algae as a golden mine for treatment of liver fibrosis: a proposal based on experimental animal study. Int J Curr Pharm Rev Res 2015;6:225-36.
8. Hui F, Qiu-kuan W, Yun-hai H, Dan-dan R. Functional effect of dietary fiber from seaweed costaria costata residues on reduce in serum lipids in mice. J Dalian Ocean Univ 2012;3:004.
9. Yildiz G, Celikler S, Vatan O, Dere S. Determination of the anti-oxidative capacity and bioactive compounds in green seaweed Ulva rigida C. Agardh. Int J Food Prop 2012;15:11829.
10. Bocanegra A, Bastida S, Benedi J, Rodenas S, Sanchez-Muniz FJ. Characteristics and nutritional and cardiovascular-health properties of seaweeds. J Med Food 2009;12:236-58.
11. Shelar PS, Reddy SVK, Shelar GS, Kavitha M, Kumar GP, Reddy G. Medicinal value of seaweeds and its applications: a review. Cont J Pharm Toxicol Res 2012;5:1-22.
12. Awang AN, Ng JL, Matanjun P, Sulaiman MR, Tan TS, Ooi YBH. Anti-obesity property of the brown seaweed, Sargassum polycystum using an in vivo animal model. J Appl Phycol 2013;1-6. Doi 10.1007/s10811-013-0149-6.
13. Bhattacharjee M. Pharmaceutically valuable bioactive compounds of algae. Asian J Pharm Clin Res 2016;9:43-7.
14. Cheong SH, Kim MY, Sok DE, Hwang SY, Kim JH, Kim HR, et al. Spirulina prevents atherosclerosis by reducing hypercholesterolemia in rabbits fed a high-cholesterol diet. J Nutr Sci Vitaminol 2010;56:34-40.
15. Torres-Duran PV, Ferreira-Hermosillo A, Juarez-Oropeza MA. Antihyperlipemic and antihypertensive effects of Spirulina maxima in an open sample of mexican population: a preliminary report. Lipids Health Dis 2007;6:33.
16. Shaish A, Harari A, Hananshvili L, Cohen H, Bitzur R, Luvish T, et al. 9-cis-Î²-carotene-rich powder of the alga Dunaliella bardawil increases plasma HDL-cholesterol in fibrate-treated patients. Atherosclerosis 2006;189:215-21.
17. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
18. Warnick GR, Knopp RH, Fitzpatrick V, Branson L. Estimating low-density lipoprotein cholesterol by the friedewald equation is adequate for classifying patients on the basis of nationally recommended cutpoints. Clin Chem 1990;36:15-9.
19. Matsubara M, Maruoka S, Katayose S. Decreased plasma adiponectin concentrations in women with dyslipidemia. J Clin Endocrinol Metab 2002;87:2764-9.
20. Limantara L, Heriyanto H. Studi komposisi pigmen dan kandungan fukosantin rumput laut cokelat dari perairan madura dengan kromatografi cair kinerja tinggi. ILMU KELAUTAN: Indonesian J Mar Sci 2010;15:23-32.
21. Mahley RW, Holcombe K. Alterations of the plasma lipoproteins and apoproteins following cholesterol feeding in the rat. J Lipid Res 1977;18:314-24.
22. Murphy C, Parini P, Wang J, Bjorkhem I, Eggertsen G, Gafvels M. Cholic acid as key regulator of cholesterol synthesis, intestinal absorption and hepatic storage in mice. BBA-Mol Cell Biol L 2005;1735:167-75.
23. Al-Noory A, Amreen A, Hymoor S. Antihyperlipidemic effects of ginger extracts in alloxan-induced diabetes and propylthiouracil-induced hypothyroidism in (rats). Pharmacogn Res 2013;5:157.
24. Kobayashi S, Terashima Y, Itoh H. The effects of dietary chitosan on liver lipid concentrations in broiler chickens treated with propylthiouracil. J Poult Sci 2006;43:162-6.
25. Zhang X, Mao S, Luo G, Wei J, Berggren-Soderlund M, Nilsson-Ehle P, et al. Effects of simvastatin on apolipoprotein M in vivo and in vitro. Lipids Health Dis 2011;10:112.
26. Getz GS, Reardon CA. Diet and murine atherosclerosis. Arterioscler Thromb Vasc Biol 2006;26:242-9.
27. Fried SK, Rao SP. Sugars, hypertriglyceridemia, and cardiovascular disease. Am J Clin Nutr 2003;78:873S-80S.
28. Law MR, Wald NJ, Thompson S. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? Br Med J 1994;308:367.
29. Chen Z, Peto R, Collins R, MacMahon S, Lu J, Li W. Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations. Br Med J 1991;303:276.
30. Martin M, Browner W, Hulley S, Kuller L, Wentworth D. Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361 662 men. Lancet 1986;328:933-6.
31. Johannesson M, Jonsson B, Kjekshus J, Olsson AG, Pedersen TR, Wedel H. Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease. New Engl J Med 1997;336:332-6.
32. Willett W. Nutritional epidemiology: monographs in epidemiology and biostatistics. Oxford: Oxford University Press; 1998.
33. Sparrow CP, Burton CA, Hernandez M, Mundt S, Hassing H, Patel S, et al. Simvastatin has anti-inflammatory and antiatherosclerotic activities independent of plasma cholesterol lowering. Arterioscler Thromb Vasc Biol 2001;21:115-21.
34. Wang Y-XJ, Martin-McNulty B, Huw LY, da Cunha V, Post J, Hinchman J, et al. Anti-atherosclerotic effect of simvastatin depends on the presence of apolipoprotein E. Atherosclerosis 2002;162:23-31.
35. Bea F, Blessing E, Bennett B, Levitz M, Wallace EP, Rosenfeld ME. Simvastatin promotes atherosclerotic plaque stability in apoE-deficient mice independently of lipid lowering. Arterioscler Thromb Vasc Biol 2002;22:1832-7.
36. Wang H, Ng T. Natural products with hypoglycemic, hypotensive, hypocholesterolemic, antiatherosclerotic and antithrombotic activities. Life Sci 1999;65:2663-77.
37. Prihastyanti M, Heriyanto, Limantara L, Trihandaru S. Photostability of the crude pigment extract from brown algae and identification of their degradation products. In: Limantara L, Heriyanto, Sadtono E. editors. Proceeding of Natural Pigments Conference for South-East Asia. Malang; 2010. p. 213-9.
38. Indrawati R, Heriyanto, Limantara L, Susanto A. Study of pigments distribution in the stem, leaf, and vesicle of Sargassum filipendula C. Agardh, Sargassum polycystum C. Agardh and other Sargassum spp. from Madura waters by HPLC. In: Limantara L, Heriyanto, Sadtono E. editors. Proceeding of Natural Pigments Conference for South-East Asia. Malang; 2010. p. 225-30.
39. Wijaya W, Heriyanto, Limantara L, Prasetyo B. The composition of pigments in three major teas by high performance liquid chromatography. In: Limantara L, Heriyanto, Sadtono E. editors. Proceeding of Natural Pigments Conference for South-East Asia. Malang; 2010. p. 237-43.
40. Palupi I, Kusmita L, Limantara L, Karwur F. Pigment composition of five Pandanus sp. In: Limantara L, Heriyanto, Sadtono E. editors. Proceeding of Natural Pigments Conference for South-East Asia. Malang; 2010. p. 294-302.
41. Hegazi MM, Ruzafa AP, Almela L, Candela ME. Separation and identification of chlorophylls and carotenoids from Caulerpa prolifera, Jania rubens and Padina pavonica by reversed-phase high-performance liquid chromatography. J Chromatogr A 1998;829:153-9.
42. Kale MA, Bindu SM, Khadkikar P. Role of antioxidants and nutrition in oxidative stress: a review. Int J Appl Pharm 2015;7:1-4.
43. Peng J, Yuan JP, Wu CF, Wang JH. Fucoxanthin, a marine carotenoid present in brown seaweeds and diatoms: metabolism and bioactivities relevant to human health. Mar Drugs 2011;9:1806-28.
44. Woo MN, Jeon SM, Shin YC, Lee MK, Kang M, Choi MS. Anti-obese property of fucoxanthin is partly mediated by altering lipid-regulating enzymes and uncoupling proteins of visceral adipose tissue in mice. Mol Nutr Food Res 2009;53:1603-11.
45. Maeda H, Hosokawa M, Sashima T, Funayama K, Miyashita K. Fucoxanthin from edible seaweed, Undaria pinnatifida, shows antiobesity effect through UCP1 expression in white adipose tissues. Biochem Biophys Res Commun 2005;332:392-7.
46. Dwyer JH, Navab M, Dwyer KM, Hassan K, Sun P, Shircore A, et al. Oxygenated carotenoid lutein and progression of early atherosclerosis the los angeles atherosclerosis study. Circulation 2001;103:2922-7.
47. Alves-Rodrigues A, Thomas B. The role of lutein in the prevention of atherosclerosis. J Am Coll Cardiol 2002;40:835.
48. Kim JE, Leite JO, Smyth JA, Clark RM, Fernandez ML. A lutein-enriched diet prevents cholesterol accumulation and decreases oxidized LDL and inflammatory cytokines in the aorta of guinea pigs. J Nutr 2011;141:1458-63.
49. Vlad M, Bordas E, Caseanu E, Uza G, Creteanu E, Polinicenco C. Effect of cuprofilin on experimental atherosclerosis. Biol Trace Elem Res 1995;48:99-109.